Sumitomo Mitsui Trust Group, Inc. leans into gold, trims AI megacaps

The biggest expression of rising conviction is in gold. IAUM was boosted by +22.3% in shares, adding about $228.8M, while GLDM also saw a modest add, lifting the combined gold ETF sleeve above 1.9% of the book. That is a clear macro statement: they are willing to pay performance drag in good times to own a convex hedge against both valuation risk in tech and policy uncertainty.

On the micro side, Walmart is the standout among individual stocks. The fund lifted WMT by +3.1% in shares, adding roughly $41.0M and nudging it to 0.89% of the portfolio — a quiet but pointed bet that US mass‑market consumption and scale retail logistics will keep compounding even if discretionary demand wobbles. Walmart is being favored while more rate‑sensitive or higher‑beta consumer names (like Costco, Home Depot, and McDonald’s) are gently cut.

Health care adds are highly selective rather than sector‑wide. Intuitive Surgical’s position grew +3.2% in shares (about $21.0M more), signaling conviction in procedure‑volume growth and the stickiness of its robotics ecosystem, even as broad pharma exposure is trimmed. Analog Devices, up +3.1% in shares (around $16.4M), is a textbook “picks‑and‑shovels” add: less headline AI than Nvidia, more mission‑critical analog content across autos, industrial, and communications.

The biggest trims by dollars are a who’s‑who of the AI and cloud complex, and the pattern is too consistent to be accidental. Nvidia, Apple, and Microsoft saw share reductions of -4.1%, -5.6%, and -5.0% respectively, freeing up more than $1.3B combined at quarter‑end prices. Alphabet’s A and C lines, Amazon, Meta, and Broadcom were all cut in a tight band around -4% to -5% of shares.

This is classic position‑sizing, not a thesis reversal. All those names are still massive winners versus cost — Alphabet sits more than +800% above average entry, Broadcom over +700%, and Nvidia more than +2500% — and remain core holdings. The manager is simply admitting that portfolio risk has become overly concentrated in one macro factor: AI‑driven multiples on a small set of US mega‑caps.

Away from tech, trims look more opportunistic and funding‑driven. Micron (-11.5% in shares) and Merck (-10.1%) stand out as the sharper cuts, consistent with recycling from more cyclical memory and mature pharma into higher‑conviction single names like Intuitive Surgical and into balance‑sheet hedges like gold. Banks (JPM, BAC, GS) and energy majors (XOM, CVX) were shaved in the mid‑single digits, suggesting no appetite to make rate‑sensitive or oil‑linked bets the swing factor in the book.

Despite the visible trims at the top, sector weights barely budged, which is the tell: this quarter was about changing the quality and shock‑absorption of the same broad exposures, not changing the exposures themselves. Technology ticked down only marginally from an estimated 53.94% to 53.56%, even as nearly every large tech name was trimmed. That means the manager left the growth engine intact while dialing down single‑name concentration.

Consumer‑facing exposure was subtly upgraded rather than expanded. Consumer discretionary weight inched from 12.77% to 12.81%, but beneath that, Walmart was added to while Costco, Home Depot, McDonald’s and Amazon were trimmed. That tilts the sleeve toward staples‑like demand and omni‑channel infrastructure instead of pure discretionary or high‑operating‑leverage plays.

The most interesting rotation is into the “Unclassified” bucket, which rose from 5.6% to 6.0% and is, in practice, a mix of gold ETFs and Berkshire Hathaway. That is the portfolio’s safety valve: gold for macro hedging and Berkshire as an all‑weather capital allocator. Real estate (Visa, Mastercard, Welltower by the screener’s label, but functionally payments plus REIT) and industrials both crept up, again not by bold repositioning but via small tilts that diversify the factor mix away from pure growth and duration.

Putting it together, the quarter says this manager still wants to own the AI future, but not naked. The tech complex — from Nvidia and Microsoft to Broadcom and analog names — remains the structural core, and with 3‑year annualized weighted performance of 26.06% and a 3‑year cumulative just over 100%, they have earned the right to keep riding it. The trims are about survivability after a -9.06% quarter, not about disowning the theme.

The simultaneous build‑up in gold (IAUM and GLDM), the quiet accumulation of Walmart, and the add to Intuitive Surgical outline their roadmap for the next phase: less dependence on multiple expansion, more on real cash flows, procedure growth, and hard‑asset insurance. If AI multiples compress or macro volatility spikes, this barbell leaves them bruised but not broken; if the rally resumes, the 53%-plus tech weight still gives ample upside.

Investors watching Sumitomo Mitsui Trust Group, Inc. should expect more of this incrementalism than big swings. Future 13Fs will likely show the same pattern: small trims to outsized winners, rotation into lower‑beta consumer, selective upgrades within health care and semis, and a persistent gold sleeve as long as valuations in their core book look rich versus their historical cost.